Physician profile
Sean Oneill
NPI 1124165089
$2,552.52
in general payments reported to CMS, 2019-2025
18 companies · $91.28 in 2025
The $91.28 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,303 · 2020: $35.76 · 2021: $244 · 2022: $334 · 2023: $502 · 2024: $42.10 · 2025: $91.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,463.10 | 2019-2023 | Clareon |
| Abbvie INC. | $159.56 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $117.46 | 2019-2023 | Eylea |
| Novartis Pharmaceuticals Corporation | $102.57 | 2019-2023 | |
| Alimera Sciences, INC. | $95.76 | 2020-2022 | |
| Rxsight INC | $91.28 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Biotissue Holdings INC. | $79.12 | 2022 | |
| Bausch & Lomb Americas INC. | $70.56 | 2022-2023 | Vyzulta |
| Rayner Intraocular Lenses Limited | $67.72 | 2022-2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Lombart Brothers, INC. | $65.15 | 2023 | Opd-III |
| Sun Pharmaceutical Industries INC. | $48.59 | 2019-2021 | |
| Omeros Corporation | $39.45 | 2021 | |
| Coopervision INC. | $39.30 | 2023-2024 | Biofinity Contact Lens, Clariti Contact Lens |
| Aerie Pharmaceuticals, INC. | $30.02 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $29.78 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.43 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $16.62 | 2022 | |
| Allergan, INC. | $13.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Oneill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.